{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T21:38:42Z","timestamp":1794951522128,"version":"4.9.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Fluids Barriers CNS"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12987-015-0008-8","type":"journal-article","created":{"date-parts":[[2015,5,14]],"date-time":"2015-05-14T07:17:47Z","timestamp":1431587867000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["The chemokine CXCL13 is elevated in the cerebrospinal fluid of patients with neurosyphilis"],"prefix":"10.1186","volume":"12","author":[{"given":"R","family":"Dersch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Hottenrott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Senel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Lehmensiek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Tumani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Rauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O","family":"Stich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,5,15]]},"reference":[{"key":"8_CR1","unstructured":"Centers for Disease Control and Prevention. Late and late latent syphilis\u2014reported cases and rates of reported cases by state\/area and region in alphabetical order, United States and outlying areas, 2009\u20132013. http:\/\/www.cdc.gov\/std\/stats13\/tables\/39.htm ."},{"key":"8_CR2","unstructured":"Robert Koch Institut. Syphilis in Deutschland 2012. Epidemiol Bull. 2013;44."},{"issue":"Pt 1","key":"8_CR3","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/brain\/awh680","volume":"129","author":"M Krumbholz","year":"2006","unstructured":"Krumbholz M, Theil D, Cepok S, Hemmer B, Kivisakk P, Ransohoff RM, et al. Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment. Brain. 2006;129(Pt 1):200\u201311.","journal-title":"Brain"},{"issue":"8","key":"8_CR4","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1136\/jnnp.2009.195438","volume":"81","author":"M Senel","year":"2010","unstructured":"Senel M, Rupprecht TA, Tumani H, Pfister HW, Ludolph AC, Brettschneider J. The chemokine CXCL13 in acute neuroborreliosis. J Neurol Neurosurg Psychiatry. 2010;81(8):929\u201333.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8_CR5","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/1742-2094-11-103","volume":"11","author":"J Hytonen","year":"2014","unstructured":"Hytonen J, Kortela E, Waris M, Puustinen J, Salo J, Oksi J. CXCL13 and neopterin concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other diseases that cause neuroinflammation. J Neuroinflammation. 2014;11:103.","journal-title":"J Neuroinflammation."},{"issue":"10","key":"8_CR6","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1128\/CVI.00353-13","volume":"20","author":"T Cerar","year":"2013","unstructured":"Cerar T, Ogrinc K, Lotric-Furlan S, Kobal J, Levicnik-Stezinar S, Strle F, et al. Diagnostic value of cytokines and chemokines in Lyme neuroborreliosis. Clin Vaccine Immunol. 2013;20(10):1578\u201384.","journal-title":"Clin Vaccine Immunol"},{"issue":"12","key":"8_CR7","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1212\/WNL.0b013e318211c39a","volume":"76","author":"C Schmidt","year":"2011","unstructured":"Schmidt C, Plate A, Angele B, Pfister HW, Wick M, Koedel U, et al. A prospective study on the role of CXCL13 in Lyme neuroborreliosis. Neurology. 2011;76(12):1051\u20138.","journal-title":"Neurology."},{"issue":"2","key":"8_CR8","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jinf.2010.11.005","volume":"62","author":"I Tjernberg","year":"2011","unstructured":"Tjernberg I, Henningsson AJ, Eliasson I, Forsberg P, Ernerudh J. Diagnostic performance of cerebrospinal fluid chemokine CXCL13 and antibodies to the C6-peptide in Lyme neuroborreliosis. J Infect. 2011;62(2):149\u201358.","journal-title":"J Infect"},{"issue":"5","key":"8_CR9","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1128\/JCM.00084-11","volume":"49","author":"ND Burgel van","year":"2011","unstructured":"van Burgel ND, Bakels F, Kroes AC, van Dam AP. Discriminating Lyme neuroborreliosis from other neuroinflammatory diseases by levels of CXCL13 in cerebrospinal fluid. J Clin Microbiol. 2011;49(5):2027\u201330.","journal-title":"J Clin Microbiol"},{"issue":"1","key":"8_CR10","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000337223","volume":"4","author":"P Albrecht","year":"2012","unstructured":"Albrecht P, Henke N, Lehmann HC, Macht S, Hefter H, Goebels N, et al. A case of relapsing-remitting neuroborreliosis? Challenges in the differential diagnosis of recurrent myelitis. Case Rep Neurol. 2012;4(1):47\u201353.","journal-title":"Case Rep Neurol."},{"key":"8_CR11","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1186\/1471-2334-12-344","volume":"12","author":"JP Borde","year":"2012","unstructured":"Borde JP, Meier S, Fingerle V, Klier C, Hubner J, Kern WV. CXCL13 may improve diagnosis in early neuroborreliosis with atypical laboratory findings. BMC Infect Dis. 2012;12:344.","journal-title":"BMC Infect Dis"},{"issue":"19","key":"8_CR12","doi-asserted-by":"crossref","first-page":"5968","DOI":"10.1158\/1078-0432.CCR-09-0108","volume":"15","author":"L Fischer","year":"2009","unstructured":"Fischer L, Korfel A, Pfeiffer S, Kiewe P, Volk HD, Cakiroglu H, et al. CXCL13 and CXCL12 in central nervous system lymphoma patients. Clin Cancer Res. 2009;15(19):5968\u201373.","journal-title":"Clin Cancer Res"},{"key":"8_CR13","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00115-014-4020-z","volume":"85","author":"TA Rupprecht","year":"2014","unstructured":"Rupprecht TA, Lechner C, Tumani H, Fingerle V. CXCL13: a biomarker for acute Lyme neuroborreliosis: investigation of the predictive value in the clinical routine. Nervenarzt. 2014;85:459\u201364.","journal-title":"Nervenarzt"},{"issue":"9","key":"8_CR14","doi-asserted-by":"crossref","first-page":"4351","DOI":"10.1128\/IAI.01642-06","volume":"75","author":"TA Rupprecht","year":"2007","unstructured":"Rupprecht TA, Kirschning CJ, Popp B, Kastenbauer S, Fingerle V, Pfister HW, et al. Borrelia garinii induces CXCL13 production in human monocytes through Toll-like receptor 2. Infect Immun. 2007;75(9):4351\u20136.","journal-title":"Infect Immun"},{"issue":"31","key":"8_CR15","first-page":"590","volume":"61","author":"Centers for Disease Control and Prevention","year":"2012","unstructured":"Centers for Disease Control and Prevention. Update to CDC\u2019s sexually transmitted diseases treatment guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections. MMWR Morb Mortal Wkly Rep. 2012;61(31):590\u20134.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"8_CR16","volume-title":"Leitlinien f\u00fcr Diagnostik und Therapie in der Neurologie","author":"DGN","year":"2012","unstructured":"DGN. S1 Leitlinie Neurosyphilis. In: Diener H-C, Weimar C, editors. Leitlinien f\u00fcr Diagnostik und Therapie in der Neurologie. Stuttgart: Thieme Verlag; 2012."},{"issue":"1","key":"8_CR17","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1469-0691.2010.03175.x","volume":"17","author":"G Stanek","year":"2011","unstructured":"Stanek G, Fingerle V, Hunfeld KP, Jaulhac B, Kaiser R, Krause A, et al. Lyme borreliosis: clinical case definitions for diagnosis and management in Europe. Clin Microbiol Infect. 2011;17(1):69\u201379.","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"8_CR18","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","volume":"69","author":"CH Polman","year":"2011","unstructured":"Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69(2):292\u2013302.","journal-title":"Ann Neurol."},{"issue":"5","key":"8_CR19","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1177\/0961203310383301","volume":"20","author":"L Schiffer","year":"2011","unstructured":"Schiffer L, Kielstein JT, Haubitz M, Luhrs H, Witte T, Haller H, et al. Elevation of serum CXCL13 in SLE as well as in sepsis. Lupus. 2011;20(5):507\u201311.","journal-title":"Lupus."},{"issue":"5","key":"8_CR20","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/OLQ.0b013e3181d877a1","volume":"37","author":"CM Marra","year":"2010","unstructured":"Marra CM, Tantalo LC, Sahi SK, Maxwell CL, Lukehart SA. CXCL13 as a cerebrospinal fluid marker for neurosyphilis in HIV-infected patients with syphilis. Sex Transm Dis. 2010;37(5):283\u20137.","journal-title":"Sex Transm Dis"},{"key":"8_CR21","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1742-2094-6-42","volume":"6","author":"TA Rupprecht","year":"2009","unstructured":"Rupprecht TA, Plate A, Adam M, Wick M, Kastenbauer S, Schmidt C, et al. The chemokine CXCL13 is a key regulator of B cell recruitment to the cerebrospinal fluid in acute Lyme neuroborreliosis. J Neuroinflammation. 2009;6:42.","journal-title":"J Neuroinflammation."}],"container-title":["Fluids and Barriers of the CNS"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-015-0008-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,7]],"date-time":"2022-05-07T23:30:27Z","timestamp":1651966227000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.fluidsbarrierscns.com\/content\/12\/1\/12"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,15]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["8"],"URL":"https:\/\/doi.org\/10.1186\/s12987-015-0008-8","relation":{},"ISSN":["2045-8118"],"issn-type":[{"value":"2045-8118","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,15]]},"article-number":"12"}}